Exclusion of patients with high vasopressor requirements is based on the CASS trial [ 26 ], which showed a trend toward increased mortality due to refractory shock in the TH arm.
← all excerpts
Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome.
1
—
—